Q4 2013 Earnings Call
February 11, 2014 8:30 am ET
Gregory P. Sargen - Chief Financial Officer, Principal Accounting Officer and Executive Vice President
Steven M. Klosk - Chief Executive Officer, President...
Investors eyeing a purchase of Cambrex Corp (NYSE: CBM) stock, but tentative about paying the going market price of $21.17/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put...
[at noodls] - The Dow Chemical Company (NYSE: DOW) and Cambrex (NYSE: CBM) celebrated the completion of the new operational facility for Dow's Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) for Drug Solubility ... Read more on this. The...
Cambrex (CBM) reached a new 52-week high of $13.44 on September 10, about a month after reporting strong second-quarter results that included a 50% earnings surprise and a raised guidance for the full year.
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Cambrex (CBM):